28171 Assessing long-term maintenance of efficacy with tralokinumab monotherapy in patients with moderate-to-severe atopic dermatitis: Combined results from two phase 3, randomized, double-blind, placebo-controlled trials (ECZTRA 1 and 2)
Andrew Blauvelt
(1)
,
Andreas Wollenberg
(2)
,
Andrew Pink
(3)
,
Ketty Peris
,
April Armstrong
(4)
,
Lynda Spelman
,
Hidehisa Saeki
(5)
,
Charles Lynde
(6)
,
Pedro Herranz
(7)
,
Sébastien Barbarot
(8)
,
Eric Simpson
(9)
1
Oregon Medical Research Center
2 University Hospital of the Ludwig-Maximilian-University Munich
3 Guy's and St Thomas' Hospitals
4 USC - University of Southern California
5 Nippon Medical School [Tokyo, Japon]
6 University of Toronto
7 Hospital Universitario La Paz
8 PhAN - Physiopathologie des Adaptations Nutritionnelles
9 OHSU - Oregon Health and Science University [Portland]
2 University Hospital of the Ludwig-Maximilian-University Munich
3 Guy's and St Thomas' Hospitals
4 USC - University of Southern California
5 Nippon Medical School [Tokyo, Japon]
6 University of Toronto
7 Hospital Universitario La Paz
8 PhAN - Physiopathologie des Adaptations Nutritionnelles
9 OHSU - Oregon Health and Science University [Portland]